Dawei Guo Selected Research

Silver

6/2023	Silver nanoparticles combat Salmonella Typhimurium: Suppressing intracellular infection and activating dendritic cells.
1/2022	Green synthesis of silver nanoparticles through oil: Promoting full-thickness cutaneous wound healing in methicillin-resistant Staphylococcus aureus infections.
1/2017	Shape-controlled fabrication of magnetite silver hybrid nanoparticles with high performance magnetic hyperthermia.
10/2015	A caffeic acid mediated facile synthesis of silver nanoparticles with powerful anti-cancer activity.
4/2014	The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells.
10/2013	Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dawei Guo Research Topics

Disease

15	Neoplasms (Cancer) 01/2024 - 02/2010
5	Neoplasm Metastasis (Metastasis) 12/2023 - 02/2010
5	Cardiotoxicity 08/2023 - 02/2018
4	Infections 06/2023 - 08/2018
4	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 10/2011
4	Leukemia 05/2017 - 10/2013
3	Coccidiosis 02/2023 - 02/2018
3	Triple Negative Breast Neoplasms 09/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2021
2	Atherosclerosis 08/2023 - 01/2020
2	Necrosis 02/2023 - 03/2018
2	Hemorrhage 01/2023 - 01/2022
2	COVID-19 07/2022 - 01/2022
2	Weight Loss (Weight Reduction) 09/2021 - 10/2020
2	Vomiting 01/2021 - 01/2021
2	Inflammation (Inflammations) 01/2020 - 01/2020
2	Lymphatic Metastasis 10/2016 - 02/2010
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2015 - 04/2014
2	Kashin-Beck Disease 12/2011 - 10/2011
2	Osteoarthritis 12/2011 - 10/2011
1	Esophageal Squamous Cell Carcinoma 01/2024
1	Persistent Infection 06/2023
1	Frailty 01/2023
1	Myocardial Infarction 01/2023
1	Lung Neoplasms (Lung Cancer) 12/2022
1	Type 2 Diabetes Mellitus (MODY) 07/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Toxic Optic Neuropathy 01/2022
1	Coinfection 12/2021
1	Urinary Incontinence 09/2021
1	Bacterial Infections (Bacterial Infection) 02/2021
1	Anorexia 01/2021
1	Poisoning 01/2021
1	Rhabdomyolysis 10/2020
1	Body Weight (Weight, Body) 10/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2020
1	Cognitive Dysfunction 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2018

Drug/Important Bio-Agent (IBA)

8	maduramicinIBA 12/2023 - 03/2018
6	SilverIBA 06/2023 - 10/2013
5	MicellesIBA 12/2023 - 01/2019
4	tocophersolanIBA 12/2023 - 01/2021
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2023 - 02/2018
3	IonophoresIBA 10/2020 - 02/2018
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2013
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2012 - 02/2010
2	oxidized low density lipoproteinIBA 08/2023 - 01/2020
2	Therapeutic UsesIBA 06/2023 - 01/2021
2	Succinic Acid (Succinate)IBA 02/2023 - 01/2021
2	Tocopherols (Tocopherol)IBA 02/2023 - 01/2021
2	polyethylene glycol 1000IBA 02/2023 - 01/2021
2	Chloroquine (Aralen)FDA LinkGeneric 07/2022 - 01/2022
2	halofuginoneIBA 01/2022 - 01/2021
2	tilmicosinIBA 02/2021 - 03/2020
2	MycotoxinsIBA 01/2021 - 01/2021
2	deoxynivalenolIBA 01/2021 - 01/2021
2	Long Noncoding RNAIBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 11/2015 - 02/2014
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	PolymersIBA 02/2023
1	cholesterol 25-hydroxylaseIBA 12/2022
1	chloroquine diphosphate FDA LinkGeneric 07/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	kaempferolIBA 12/2021
1	AntitoxinsIBA 12/2021
1	QuercetinIBA 12/2021
1	Hemolysin Proteins (Hemolysins)IBA 12/2021
1	FlavonoidsIBA 12/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	AlkaloidsIBA 01/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 01/2021
1	neuropeptide Y2 receptorIBA 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 01/2021
1	QuinazolinonesIBA 01/2021
1	Granisetron (Kytril)FDA LinkGeneric 01/2021
1	febrifugineIBA 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	Malondialdehyde (Propanedial)IBA 01/2020
1	Small Nucleolar RNA (snoRNA)IBA 01/2020
1	CytokinesIBA 01/2020
1	taxaneIBA 01/2019
1	MDB5IBA 01/2019
1	LuciferasesIBA 01/2019
1	QW-296IBA 01/2019
1	monomethoxypolyethylene glycol (MPEG)IBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	salinomycinIBA 02/2018
1	Matrix Metalloproteinases (MMPs)IBA 02/2018

Therapy/Procedure

6	Therapeutics 06/2023 - 02/2015
1	Oral Administration 12/2023
1	Percutaneous Coronary Intervention 01/2023
1	Patient Readmission 01/2023
1	Intravenous Injections 01/2022
1	Home Nursing (Nursing, Home) 09/2021
1	Subcutaneous Injections 01/2021
1	Castration 01/2019